The efficacy of cPED for TMA

Evaluating the efficacy of continuous plasma exchange with dialysis in patient with thrombotic microangiopathy (Evaluating the treatment efficacy of cPED in patient with TMA)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs022190024

Enrollment

Registered

2020-03-31

Start date

2020-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombotic microangiopathy

Interventions

cPED therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The thrombotic microangiopathy patients whose physician presume that plasma exchange is effective.

Exclusion criteria

Exclusion criteria: Patients deemed inappropriate by the study director.

Design outcomes

Primary

Measure	Time frame
Changes in platelet counts before and after cPED	—

Secondary

Measure	Time frame
1. Incidence of adverse events. 2. Changes in blood test data before and after cPED. 3. Changes in severity assessment scores before and after cPED. 4. Number of days in ICU. 5. 28-day survival or discharge survival.	—

Contacts

Public ContactKasumi Satoh

Akita University Hospital

satohkasumi@med.akita-u.ac.jp+81-18-884-6185

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026